NOVEL Novel brain health solutions across four focus areas: Prevention and care, Methods and data, Innovation and society, and Ethics and well-being
- Coordinator
- Ita-Suomen Yliopisto, Finland
- Runs
- 1 December 2024 to 30 November 2029
- Status
- Running
- EU funding
- €2.0m
- Total cost
- —
- Partners
- 37 organisations in 11 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101179145
What the project is doing
In the project's own words, from its summary on CORDIS.
The NOVEL Postdoctoral Programme pioneers in merging diverse socio-cultural and scientific expertise to forge new brain health solutions, energizing regional, national and global development. It integrates neuroscience, data science, innovation management, and social and legal studies across four synergetic research areas: Prevention and Care, Methods and Data, Innovation and Society, Ethics and Wellbeing. This initiative thrives on cooperation with companies, health organizations, patient groups, and universities, offering a rich training blend through compulsory non-academic secondments, mentoring, and dynamic summer schools.
Targeting under-represented and minority scientists across different disciplines, NOVEL encourages applicants to work on their research projects within an inclusive community-based platform, ensuring equal opportunities. The merit-based selection process is transparent, conducted by external international assessors. NOVEL’s training goals are multifaceted: nurturing research excellence and inclusivity, fostering broad intersectoral networks, embracing Open Science, and aspiring to be a global benchmark in brain health research training.
The training is structured into three pillars: enhancing disciplinary skills, developing transferable competencies in innovation, management, leadership, and ethics, and boosting active parnerships and stakeholder engagement. Mandatory and optional secondments with NOVEL partners underscore its comprehensive intersectoral approach. The programme promises attractive employment conditions, including 36-month contracts, competitive compensation, strong local support systems, and an inspiring environment for research and collaboration.
Each fellow receives guidance from multiple supervisors and a mentor, facilitating both conventional and innovative career trajectories, positioning NOVEL at the forefront of research training in brain health.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Ita-Suomen Yliopisto | Kuopio | Finland | Coordinator |
| Icometrix NV | Leuven | Belgium | Associatedpartner |
| Universiteit Antwerpen | Antwerpen | Belgium | Associatedpartner |
| Royal Institution for the Advancement of Learning Mcgill University | Montreal | Canada | Associatedpartner |
| Eberhard Karls Universitaet Tuebingen | Tuebingen | Germany | Associatedpartner |
| Technische Universitaet Muenchen | Muenchen | Germany | Associatedpartner |
| CoNurse OÜ | Tallinn | Estonia | Associatedpartner |
| Institut De Recerca De L'hospital De La Santa Creu I Sant Pau Fundacion | Barcelona | Spain | Associatedpartner |
| Audicin Oy | Helsinki | Finland | Associatedpartner |
| Brain Relief Academy Oy | Kuopio | Finland | Associatedpartner |
| Charles River Discovery Research Services Finland Oy | Kuopio | Finland | Associatedpartner |
| Combinostics Oy | Tampere | Finland | Associatedpartner |
| Epilepsialiitto ry, Epilepsiförbundet rf | Helsinki | Finland | Associatedpartner |
| Finnadvance Oy | Helsinki | Finland | Associatedpartner |
| Kuopio Health Co-Op | Kuopio | Finland | Associatedpartner |
| Liikehäiriösairauksien liitto ry | Turku | Finland | Associatedpartner |
| Marginum Oy | Tampere | Finland | Associatedpartner |
| Muistiliitto | Helsinki | Finland | Associatedpartner |
| Novartis Finland Oy | Espoo | Finland | Associatedpartner |
| Orion Oyj | Espoo | Finland | Associatedpartner |
| Pohjois-Savon Hyvinvointialue | Kuopio | Finland | Associatedpartner |
| Samfundet Folkhalsan I Svenska Finland Rf | Helsinki | Finland | Associatedpartner |
| Suomen Punainen Risti | Helsinki | Finland | Associatedpartner |
| StellarQ | Turku | Finland | Associatedpartner |
| Suomen Aivosäätiö Sr | Helsinki | Finland | Associatedpartner |
| Tampereen Korkeakoulusaatio Sr | Tampere | Finland | Associatedpartner |
| Turun Yliopisto | Turku | Finland | Associatedpartner |
| Wellpro Impact Solutions Oy | Jyväskylä | Finland | Associatedpartner |
| Biotalentum Tudasfejleszto Kft | Goedoello | Hungary | Associatedpartner |
| Universitetet I Oslo | Oslo | Norway | Associatedpartner |
| Bioarctic AB | Stockholm | Sweden | Associatedpartner |
| Basic Genomics AB | Solna | Sweden | Associatedpartner |
| Karolinska Institutet | Stockholm | Sweden | Associatedpartner |
| Esya Ltd. | London | United Kingdom | Associatedpartner |
| The University of Birmingham | Birmingham | United Kingdom | Associatedpartner |
| University College London | London | United Kingdom | Associatedpartner |
| Regents of University of Minnesota | Minneapolis Mn | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI